A study of factors which predicts the therapeutic effect of acotiamide on abdominal symptoms in patients with Functional dyspepsia.
- Conditions
- Functional dyspepsia
- Registration Number
- JPRN-UMIN000036265
- Lead Sponsor
- Akita University Graduate School of Medicine Department of Gastroenterology and Neurology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Not provided
1) Those that have been prescribed acid secretion inhibitors and digestive tract movement improving agents within one month. 2) Person who are taking non-steroidal analgesics,steroids, immunosuppressants 3) Endoscopic examination with organic abnormalities that cause symptoms such as erosive reflux esophagitis 4) There is no problem if heartburn and IBS symptoms accompany, but heartburn and IBS symptoms dominate 5) Person who is suspected of mental illness 6) Potentially pregnant, pregnant 7) Person who have serious systemic illness 8) Person who have a history of upper abdominal surgery for esophagus, stomach and duodenum (except for endoscopic treatment), or if you are planning 9) Person who have uncontrolled diabetes 10) Those who received H. pylori eradication treatment within 6 months 11) In addition, those who the research investigator or co-investigator judged as inappropriate for study participation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of effects on GOS and OTE questionnaires at 2 and 4 weeks of medication
- Secondary Outcome Measures
Name Time Method Serum helicobacter pylori antibody Serum pepsinogen levels Adverse events, medication status, presence of constipation, duration of illness, symptoms, endoscopic findings